Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Dalfampridine

Dalfampridine Impurities

Dalfampridine (also known as 4-aminopyridine) is a potassium channel blocker that is used to improve walking in patients with multiple sclerosis. Its impurity profile includes structurally related analogs, residual solvents, and degradation products. These pharmaceutical impurities can be formed under stress conditions such as hydrolysis, oxidation, and photolysis. Typical degradation pathways of Dalfampridine may involve oxidative breakdown of the pyridine ring, hydrolytic cleavage of amine groups, and rearrangement of substituents within the heteroaromatic scaffold. These impurities may affect the potency, stability, and safety of the drug. Thus, all Dalfampridine impurities must be structurally characterized and qualified according to ICH guidelines for toxicological assessment and analytical validation.

Dalfampridine EP Impurities

We provide the pharmacopeial and non-pharmacopeial Dalfampridine impurity compounds that are available in compliance with European Pharmacopoeia (EP) specifications. These standards can support analytical method development, impurity profiling, and long-term stability studies. Thus, EP traceable products are supplied with validated analytical data, including purity, structural confirmation, and spectral characterization.

Dalfampridine Related Compounds

Structurally related compounds and synthetic analogs of Dalfampridine are included for impurity identification, toxicological qualification, and regulatory submission. These related substances are used in forced degradation studies, genotoxicity assessments, and impurity threshold evaluations. They are essential for understanding the impurity profile and ensuring compliance with regulatory limits.

Dalfampridine Impurity Reference Standards

We also provide the Dalfampridine impurity reference standards, which are available with validated analytical data, including purity, NMR, MS, and full Certificates of Analysis. These standards are used in pharmaceutical research, method validation, and GMP-compliant quality control. Hence, EP/USP traceable products are available upon request and are routinely re-tested to ensure consistency and reliability.

Please enquire for price & pack size
PLEASE ENQUIRE

CAS No.

: 100130-15-2

Mol F.

: C5H6N2O4S

Mol W.

: 190.18

Cat No.

: SA82810

Please enquire for price & pack size
PLEASE ENQUIRE

CAS No.

: 504-24-5

Mol F.

: C5H6N2

Mol W.

: 94.1

Cat No.

: SA82801

Please enquire for price & pack size
PLEASE ENQUIRE

CAS No.

: 35486-42-1

Mol F.

: C5H4Br2N2

Mol W.

: 251.9

Cat No.

: SA82805

Please enquire for price & pack size
PLEASE ENQUIRE

CAS No.

: 52382-48-6

Mol F.

: C10H10N4

Mol W.

: 186.2

Cat No.

: SA82806

Please enquire for price & pack size
PLEASE ENQUIRE

CAS No.

: 4589-32-6

Mol F.

: C11H12N4

Mol W.

: 200.2

Cat No.

: SA82802

Please enquire for price & pack size
PLEASE ENQUIRE

CAS No.

: 54433-74-8

Mol F.

: C8H10N2

Mol W.

: 134.2

Cat No.

: SA82808

Please enquire for price & pack size
PLEASE ENQUIRE

CAS No.

: 3535-75-9

Mol F.

: C5H6N2O

Mol W.

: 110.12

Cat No.

: SA82800

Please enquire for price & pack size
PLEASE ENQUIRE

CAS No.

: NA

Mol F.

: C11H12N4

Mol W.

: 200.2

Cat No.

: SA82807

Please enquire for price & pack size
PLEASE ENQUIRE

CAS No.

: 84539-34-4

Mol F.

: C5H4Br2N2

Mol W.

: 251.9

Cat No.

: SA82803

Please enquire for price & pack size
PLEASE ENQUIRE

CAS No.

: 39642-87-0

Mol F.

: C11H10N4O

Mol W.

: 214.2

Cat No.

: SA82804

Please enquire for price & pack size
PLEASE ENQUIRE

CAS No.

: 52334-53-9

Mol F.

: C5H6N2O

Mol W.

: 110.11

Cat No.

: SA82809

Registration

Register to add the product to RFQ list

Already have an account?